Follow the people · Insider
Gary C. Evans
Gary C. Evans files insider transactions with the SEC as a chairman & ceo of United States Antimony (UAMY). We hold 1 disclosed purchase or sale filed since 26 January 2006, 1 of them in the last 90 days.
- Files forUAMY
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure28 August 2026
Positions held
9 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 6 December 2022 — 28 August 2026Chairman & CEO · United States Antimony (UAMY)33 Form 4 lines · source: SEC Form 4
- Filed 25 January 2006 — 17 June 2021Director · Novavax (NVAX)69 Form 4 lines · source: SEC Form 4
- Filed 8 January 2016 — 8 January 2016Chairman and CEO · Magnum Hunter Resources (MHRCQ)1 Form 4 line · source: SEC Form 4
- Filed 10 December 2015 — 10 December 2015Chairman and CEO · Magnum Hunter Resources (MHRC)1 Form 4 line · source: SEC Form 4
- Filed 5 November 2009 — 30 March 2015Chairman and CEO · Magnum Hunter Resources (MHR)38 Form 4 lines · source: SEC Form 4
- Filed 23 January 2015 — 23 January 2015Chairman and Interim CEO · GreenHunter Resources (grh)1 Form 4 line · source: SEC Form 4
- Filed 22 February 2008 — 19 December 2014Chairman and Interim CEO · GreenHunter Resources (GRH)30 Form 4 lines · source: SEC Form 4
- Filed 6 March 2008 — 31 July 2008Director · Novavax (nvax)3 Form 4 lines · source: SEC Form 4
- Filed 3 November 2006 — 3 November 2006President & CEO · Orion Ethanol (OEHL)1 Form 4 line · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 20,000 shares of United States AntimonySEC Form 428 August 2026Common Stock · traded 28 August 2026 · filed 28 August 2026
- was granted 304,524 shares of United States Antimony (a derivative holding)SEC Form 430 March 2026Common Stock · traded 15 January 2026 · filed 30 March 2026
- was granted 308,133 shares of United States Antimony (a derivative holding)SEC Form 430 March 2026Stock Option · traded 15 January 2026 · filed 30 March 2026
- was granted 304,524 shares of United States Antimony (a derivative holding)SEC Form 430 March 2026Common Stock · traded 15 January 2026 · filed 30 March 2026
- was granted 308,133 shares of United States Antimony (a derivative holding)SEC Form 430 March 2026Stock Option · traded 15 January 2026 · filed 30 March 2026
- returned to the issuer 100,000 shares of United States AntimonySEC Form 427 March 2026Common Stock · traded 25 March 2026 · filed 27 March 2026
- returned to the issuer 100,000 shares of United States AntimonySEC Form 427 March 2026Common Stock · traded 25 March 2026 · filed 27 March 2026
- returned to the issuer 100,000 shares of United States AntimonySEC Form 427 March 2026Common Stock · traded 25 March 2026 · filed 27 March 2026
- returned to the issuer 100,000 shares of United States AntimonySEC Form 427 March 2026Common Stock · traded 25 March 2026 · filed 27 March 2026
- returned to the issuer 100,000 shares of United States AntimonySEC Form 427 March 2026Common Stock · traded 25 March 2026 · filed 27 March 2026
- returned to the issuer 100,000 shares of United States AntimonySEC Form 427 March 2026Common Stock · traded 25 March 2026 · filed 27 March 2026
- returned to the issuer 100,000 shares of United States AntimonySEC Form 427 March 2026Common Stock · traded 25 March 2026 · filed 27 March 2026
- returned to the issuer 100,000 shares of United States AntimonySEC Form 427 March 2026Common Stock · traded 25 March 2026 · filed 27 March 2026
- was granted 750,000 shares of United States Antimony (a derivative holding)SEC Form 430 September 2025Common Stock · traded 27 May 2025 · filed 30 September 2025
- was granted 750,000 shares of United States Antimony (a derivative holding)SEC Form 430 September 2025Stock Option · traded 27 May 2025 · filed 30 September 2025
- ▲ bought on the open market 100,000 shares of United States AntimonySEC Form 430 September 2025Common Stock · traded 26 September 2025 · filed 30 September 2025
- ▲ bought on the open market 200,000 shares of United States AntimonySEC Form 411 December 2024Common Stock · traded 10 December 2024 · filed 11 December 2024
- was granted 750,000 shares of United States Antimony (a derivative holding)SEC Form 422 May 2024Stock Option · traded 1 March 2024 · filed 22 May 2024
- was granted 250,000 shares of United States AntimonySEC Form 422 May 2024Common Stock · traded 1 March 2024 · filed 22 May 2024
- ▲ bought on the open market 300 shares of United States AntimonySEC Form 420 January 2023UAMY-Common Stock · traded 18 January 2023 · filed 20 January 2023
- ▲ bought on the open market 21,068 shares of United States AntimonySEC Form 420 January 2023UAMY-Common Stock · traded 19 January 2023 · filed 20 January 2023
- ▲ bought on the open market 31,369 shares of United States AntimonySEC Form 417 January 2023UAMY-Common Stock · traded 13 January 2023 · filed 17 January 2023
- ▲ bought on the open market 5,137 shares of United States AntimonySEC Form 417 January 2023UAMY-Common Stock · traded 11 January 2023 · filed 17 January 2023
- ▲ bought on the open market 20,944 shares of United States AntimonySEC Form 417 January 2023UAMY-Common Stock · traded 12 January 2023 · filed 17 January 2023
- ▲ bought on the open market 147,994 shares of United States AntimonySEC Form 421 December 2022UAMY-Common Stock · traded 16 December 2022 · filed 21 December 2022
- ▲ bought on the open market 13,999 shares of United States AntimonySEC Form 421 December 2022UAMY-Common Stock · traded 10 December 2022 · filed 21 December 2022
- ▲ bought on the open market 119,201 shares of United States AntimonySEC Form 416 December 2022Common Stock · traded 15 December 2022 · filed 16 December 2022
- ▲ bought on the open market 238,212 shares of United States AntimonySEC Form 415 December 2022UAMY - Common Stock · traded 13 December 2022 · filed 15 December 2022
- ▲ bought on the open market 68,990 shares of United States AntimonySEC Form 415 December 2022UAMY - Common Stock · traded 14 December 2022 · filed 15 December 2022
- ▲ bought on the open market 251,281 shares of United States AntimonySEC Form 412 December 2022UAMY - Common Stock · traded 7 December 2022 · filed 12 December 2022
- ▲ bought on the open market 51,653 shares of United States AntimonySEC Form 412 December 2022UAMY - Common Stock · traded 8 December 2022 · filed 12 December 2022
- ▲ bought on the open market 65,902 shares of United States AntimonySEC Form 412 December 2022UAMY - Common Stock · traded 9 December 2022 · filed 12 December 2022
- ▲ bought on the open market 40,000 shares of United States AntimonySEC Form 49 December 2022UAMY-Common Stock · traded 6 December 2022 · filed 9 December 2022
- exercised options over 3,450 shares of NovavaxSEC Form 422 June 2021Common Stock · traded 17 June 2021 · filed 22 June 2021
- exercised options over 3,450 shares of Novavax (a derivative holding)SEC Form 422 June 2021Restricted Stock Units · traded 17 June 2021 · filed 22 June 2021
- ▼ sold on the open market 625 shares of NovavaxSEC Form 43 June 2021Common Stock · traded 1 June 2021 · filed 3 June 2021
- exercised options over 2,000 shares of Novavax (a derivative holding)SEC Form 417 March 2021Stock Option (Right to Buy) · traded 15 March 2021 · filed 17 March 2021
- exercised options over 4,500 shares of Novavax (a derivative holding)SEC Form 417 March 2021Stock Option (Right to Buy) · traded 15 March 2021 · filed 17 March 2021
- exercised options over 18,000 shares of Novavax (a derivative holding)SEC Form 417 March 2021Stock Option (Right to Buy) · traded 15 March 2021 · filed 17 March 2021
- exercised options over 2,000 shares of NovavaxSEC Form 417 March 2021Common Stock · traded 15 March 2021 · filed 17 March 2021
- exercised options over 4,500 shares of NovavaxSEC Form 417 March 2021Common Stock · traded 15 March 2021 · filed 17 March 2021
- exercised options over 18,000 shares of NovavaxSEC Form 417 March 2021Common Stock · traded 15 March 2021 · filed 17 March 2021
- ▼ sold on the open market 9,732 shares of NovavaxSEC Form 417 March 2021Common Stock · traded 15 March 2021 · filed 17 March 2021
- ▼ sold on the open market 14,768 shares of NovavaxSEC Form 417 March 2021Common Stock · traded 15 March 2021 · filed 17 March 2021
- exercised options over 1,000 shares of Novavax (a derivative holding)SEC Form 420 August 2020Stock Option (Right to Buy) · traded 18 August 2020 · filed 20 August 2020
- exercised options over 1,500 shares of Novavax (a derivative holding)SEC Form 420 August 2020Stock Option (Right to Buy) · traded 18 August 2020 · filed 20 August 2020
- exercised options over 4,000 shares of Novavax (a derivative holding)SEC Form 420 August 2020Stock Option (Right to Buy) · traded 18 August 2020 · filed 20 August 2020
- exercised options over 4,000 shares of Novavax (a derivative holding)SEC Form 420 August 2020Stock Option (Right to Buy) · traded 18 August 2020 · filed 20 August 2020
- exercised options over 1,000 shares of NovavaxSEC Form 420 August 2020Common Stock · traded 18 August 2020 · filed 20 August 2020
- exercised options over 1,500 shares of NovavaxSEC Form 420 August 2020Common Stock · traded 18 August 2020 · filed 20 August 2020
- exercised options over 4,000 shares of NovavaxSEC Form 420 August 2020Common Stock · traded 18 August 2020 · filed 20 August 2020
- exercised options over 4,000 shares of NovavaxSEC Form 420 August 2020Common Stock · traded 18 August 2020 · filed 20 August 2020
- ▼ sold on the open market 10,500 shares of NovavaxSEC Form 420 August 2020Common Stock · traded 18 August 2020 · filed 20 August 2020
- was granted 6,900 shares of Novavax (a derivative holding)SEC Form 426 June 2020Stock Option (Right to buy) · traded 25 June 2020 · filed 26 June 2020
- was granted 3,450 shares of Novavax (a derivative holding)SEC Form 426 June 2020Restricted Stock Units · traded 25 June 2020 · filed 26 June 2020
- was granted 18,000 shares of Novavax (a derivative holding)SEC Form 416 December 2019Stock Option (Right to buy) · traded 12 December 2019 · filed 16 December 2019
- was granted 90,000 shares of Novavax (a derivative holding)SEC Form 414 December 2018Stock Option (Right to buy) · traded 13 December 2018 · filed 14 December 2018
- was granted 80,000 shares of Novavax (a derivative holding)SEC Form 419 December 2017Stock Option (Right to buy) · traded 15 December 2017 · filed 19 December 2017
- was granted 80,000 shares of Novavax (a derivative holding)SEC Form 420 March 2017Stock Option (Right to buy) · traded 16 March 2017 · filed 20 March 2017
- ▼ sold on the open market 18,998 shares of NovavaxSEC Form 47 June 2016Common Stock · traded 6 June 2016 · filed 7 June 2016
- ▼ sold on the open market 33,866 shares of NovavaxSEC Form 425 May 2016Common Stock · traded 23 May 2016 · filed 25 May 2016
- ▼ sold on the open market 16,134 shares of NovavaxSEC Form 425 May 2016Common Stock · traded 24 May 2016 · filed 25 May 2016
- was granted 40,000 shares of Novavax (a derivative holding)SEC Form 417 March 2016Stock Option (Right to buy) · traded 15 March 2016 · filed 17 March 2016
- exercised options over 50,000 shares of NovavaxSEC Form 418 February 2016Common Stock · traded 17 February 2016 · filed 18 February 2016
- exercised options over 50,000 shares of Novavax (a derivative holding)SEC Form 418 February 2016Stock Option (Right to buy) · traded 17 February 2016 · filed 18 February 2016
- acquired or disposed of, other 99,000 shares of Magnum Hunter ResourcesSEC Form 412 January 2016Common Stock, $0.01 par value · traded 8 January 2016 · filed 12 January 2016
- had shares withheld for tax on 45,579 shares of Magnum Hunter ResourcesSEC Form 414 December 2015Common Stock, $0.01 par value · traded 10 December 2015 · filed 14 December 2015
- ▼ sold on the open market 20,000 shares of NovavaxSEC Form 426 August 2015Common Stock · traded 24 August 2015 · filed 26 August 2015
- exercised options over 15,000 shares of NovavaxSEC Form 417 August 2015Common Stock · traded 13 August 2015 · filed 17 August 2015
- exercised options over 30,000 shares of NovavaxSEC Form 417 August 2015Common Stock · traded 13 August 2015 · filed 17 August 2015
- ▼ sold on the open market 6,002 shares of NovavaxSEC Form 417 August 2015Common Stock · traded 13 August 2015 · filed 17 August 2015
- exercised options over 15,000 shares of Novavax (a derivative holding)SEC Form 417 August 2015Stock Option (Right to buy) · traded 13 August 2015 · filed 17 August 2015
- exercised options over 30,000 shares of Novavax (a derivative holding)SEC Form 417 August 2015Stock Option (Right to buy) · traded 13 August 2015 · filed 17 August 2015
- was granted 94,862 shares of Magnum Hunter ResourcesSEC Form 41 April 2015Common Stock, $0.01 par value · traded 30 March 2015 · filed 1 April 2015
- was granted 40,000 shares of Novavax (a derivative holding)SEC Form 49 March 2015Stock Option (Right to buy) · traded 5 March 2015 · filed 9 March 2015
- ▲ bought on the open market 166,666 shares of GreenHunter ResourcesSEC Form 427 January 2015COMMON STOCK, PAR VALUE $.001 · traded 23 January 2015 · filed 27 January 2015
- was granted 1,500,000 shares of GreenHunter ResourcesSEC Form 423 December 2014COMMON STOCK, PAR VALUE $.001 · traded 19 December 2014 · filed 23 December 2014
- had shares withheld for tax on 45,593 shares of Magnum Hunter ResourcesSEC Form 423 December 2014Common Stock, $0.01 par value · traded 19 December 2014 · filed 23 December 2014
- exercised options over 15,000 shares of NovavaxSEC Form 418 December 2014Common Stock · traded 16 December 2014 · filed 18 December 2014
- exercised options over 235,000 shares of NovavaxSEC Form 418 December 2014Common Stock · traded 16 December 2014 · filed 18 December 2014
- ▼ sold on the open market 46,701 shares of NovavaxSEC Form 418 December 2014Common Stock · traded 16 December 2014 · filed 18 December 2014
- exercised options over 15,000 shares of Novavax (a derivative holding)SEC Form 418 December 2014Stock Option (Right to buy) · traded 16 December 2014 · filed 18 December 2014
- exercised options over 35,000 shares of Novavax (a derivative holding)SEC Form 418 December 2014Stock Option (Right to buy) · traded 16 December 2014 · filed 18 December 2014
- exercised options over 200,000 shares of Novavax (a derivative holding)SEC Form 418 December 2014Stock Option (Right to buy) · traded 16 December 2014 · filed 18 December 2014
- ▼ sold on the open market 30,000 shares of NovavaxSEC Form 416 December 2014Common Stock · traded 12 December 2014 · filed 16 December 2014
- was granted 500,000 shares of Magnum Hunter ResourcesSEC Form 410 November 2014Common Stock, $0.01 par value · traded 6 November 2014 · filed 10 November 2014
- acquired or disposed of, other 2,000,000 shares of Magnum Hunter ResourcesSEC Form 414 October 2014Common Stock, $0.01 par value · traded 10 October 2014 · filed 14 October 2014
- ▲ bought on the open market 2,000 shares of GreenHunter ResourcesSEC Form 419 May 2014COMMON STOCK, PAR VALUE $.001 · traded 15 May 2014 · filed 19 May 2014
- ▲ bought on the open market 5,000 shares of GreenHunter ResourcesSEC Form 45 May 2014COMMON STOCK, PAR VALUE $.001 · traded 28 April 2014 · filed 5 May 2014
- ▲ bought on the open market 5,000 shares of GreenHunter ResourcesSEC Form 45 May 2014COMMON STOCK, PAR VALUE $.001 · traded 28 April 2014 · filed 5 May 2014
- ▲ bought on the open market 8,800 shares of GreenHunter ResourcesSEC Form 45 May 2014COMMON STOCK, PAR VALUE $.001 · traded 29 April 2014 · filed 5 May 2014
- ▲ bought on the open market 1,200 shares of GreenHunter ResourcesSEC Form 45 May 2014COMMON STOCK, PAR VALUE $.001 · traded 29 April 2014 · filed 5 May 2014
- ▲ bought on the open market 8,800 shares of GreenHunter ResourcesSEC Form 41 May 2014COMMON STOCK, PAR VALUE $.001 · traded 29 April 2014 · filed 1 May 2014
- ▲ bought on the open market 1,200 shares of GreenHunter ResourcesSEC Form 41 May 2014COMMON STOCK, PAR VALUE $.001 · traded 29 April 2014 · filed 1 May 2014
- ▲ bought on the open market 5,000 shares of GreenHunter ResourcesSEC Form 430 April 2014COMMON STOCK, PAR VALUE $.001 · traded 28 April 2014 · filed 30 April 2014
- ▲ bought on the open market 100 shares of GreenHunter ResourcesSEC Form 429 April 2014COMMON STOCK, PAR VALUE $.001 · traded 25 April 2014 · filed 29 April 2014
- ▲ bought on the open market 3,900 shares of GreenHunter ResourcesSEC Form 429 April 2014COMMON STOCK,PAR VALUE $.001 · traded 25 April 2014 · filed 29 April 2014
- was granted 30,000 shares of Novavax (a derivative holding)SEC Form 47 March 2014Stock Option (Right to buy) · traded 6 March 2014 · filed 7 March 2014
- was granted 300,000 shares of Magnum Hunter ResourcesSEC Form 413 January 2014Common Stock, $0.01 par value · traded 8 January 2014 · filed 13 January 2014
- ▲ bought on the open market 25,000 shares of Magnum Hunter ResourcesSEC Form 412 December 2013Common Stock, $0.01 par value · traded 11 December 2013 · filed 12 December 2013
- ▲ bought on the open market 5,000 shares of Magnum Hunter ResourcesSEC Form 412 December 2013Common Stock, $0.01 par value · traded 11 December 2013 · filed 12 December 2013
- exercised in-the-money options over 3,479 shares of Magnum Hunter ResourcesSEC Form 412 December 2013Common Stock, $0.01 par value · traded 13 September 2013 · filed 12 December 2013
- ▼ sold on the open market 39,000 shares of NovavaxSEC Form 426 April 2013Common Stock · traded 24 April 2013 · filed 26 April 2013
- ▼ sold on the open market 40,000 shares of NovavaxSEC Form 426 April 2013Common Stock · traded 24 April 2013 · filed 26 April 2013
- was granted 30,000 shares of Novavax (a derivative holding)SEC Form 46 March 2013Options-right to buy · traded 2 March 2013 · filed 6 March 2013
- was granted 1,111,111 shares of GreenHunter EnergySEC Form 424 January 2013Common Stock, Par value $.001 · traded 23 January 2013 · filed 24 January 2013
- was granted 214,359 shares of GreenHunter EnergySEC Form 424 January 2013Common Stock, Par value $.001 · traded 23 January 2013 · filed 24 January 2013
- was granted 750,000 shares of Magnum Hunter Resources (a derivative holding)SEC Form 422 January 2013Employee Stock Option - Right to buy · traded 17 January 2013 · filed 22 January 2013
- exercised in-the-money options over 8,670 shares of Magnum Hunter Resources (a derivative holding)SEC Form 47 November 2012Right to buy - Common Stock Warrants · traded 29 October 2012 · filed 7 November 2012
- exercised in-the-money options over 8,670 shares of Magnum Hunter ResourcesSEC Form 47 November 2012Common Stock, $0.01 par value · traded 5 November 2012 · filed 7 November 2012
- exercised in-the-money options over 4,186 shares of Magnum Hunter ResourcesSEC Form 47 November 2012Common Stock, $0.01 par value · traded 16 August 2012 · filed 7 November 2012
- ▼ sold on the open market 100,000 shares of Magnum Hunter ResourcesSEC Form 429 June 2012Common Stock, $0.01 par value · traded 27 June 2012 · filed 29 June 2012
- ▼ sold on the open market 100,000 shares of Magnum Hunter ResourcesSEC Form 429 June 2012Common Stock, $0.01 par value · traded 29 June 2012 · filed 29 June 2012
- ▼ sold on the open market 75,000 shares of Magnum Hunter ResourcesSEC Form 419 June 2012Common Stock, $0.01 par value · traded 15 June 2012 · filed 19 June 2012
- ▼ sold on the open market 50,000 shares of Magnum Hunter ResourcesSEC Form 413 June 2012Common Stock, $0.01 par value · traded 11 June 2012 · filed 13 June 2012
- was granted 750,000 shares of Magnum Hunter Resources (a derivative holding)SEC Form 417 April 2012Employee Stock Option - Right to Buy · traded 13 April 2012 · filed 17 April 2012
- was granted 20,000 shares of Novavax (a derivative holding)SEC Form 48 March 2012Options-right to buy · traded 1 March 2012 · filed 8 March 2012
- ▲ bought on the open market 5,000 shares of GreenHunter EnergySEC Form 45 January 2012COMMON STOCK · traded 3 January 2012 · filed 5 January 2012
- ▲ bought on the open market 5,000 shares of GreenHunter EnergySEC Form 45 January 2012COMMON STOCK · traded 3 January 2012 · filed 5 January 2012
- ▼ sold on the open market 250,000 shares of Magnum Hunter ResourcesSEC Form 45 October 2011Common Stock, $0.01 par value · traded 3 October 2011 · filed 5 October 2011
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.